You are here Home Resources and guidance Sponsors Ipsen Pty Ltd Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type ARTG (24) Prescription medicine registration (15) Designation or determination (7) Australian public assessment report (AusPar) (6) Cancellation by sponsor (4) Prescription medicine decision summary (3) Cancellation for failure to pay annual charge (1) Prescription medicine evaluation (1) Date 2026 (2) 2025 (13) 2024 (5) 2023 (9) 2022 (2) 2021 (5) 2020 (2) 2019 (3) 2018 (9) 2015 (2) 2011 (1) 2010 (1) 2007 (1) 2006 (2) 2003 (3) 2000 (1) Search Sponsor content61 result(s) found, displaying 61 to 61 DYSPORT clostridium botulinum type A toxin - haemagglutinin complex 500 Ipsen Units powder for injection vial (74124) 16 June 2000 ARTG Australian Register of Therapeutic Goods (ARTG) information for DYSPORT clostridium botulinum type A toxin - haemagglutinin complex 500 Ipsen Units powder for injection vial. Pages First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Current page 7
DYSPORT clostridium botulinum type A toxin - haemagglutinin complex 500 Ipsen Units powder for injection vial (74124) 16 June 2000 ARTG Australian Register of Therapeutic Goods (ARTG) information for DYSPORT clostridium botulinum type A toxin - haemagglutinin complex 500 Ipsen Units powder for injection vial.